A Phase III study of FP187 for the treatment of relapsing remitting multiple sclerosis (RRMS) in patients.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Dimethyl fumarate (Primary) ; Interferon beta
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 01 Sep 2016 According to a Forward Pharma media release, the company anticipates to start this clinical study in the first half of 2017.
- 08 Sep 2015 According to Forward Pharma media release, company is planning to initiate this trial in the first half of 2016.
- 22 Jul 2015 New trial record